Companies: 10,638     total market cap: S$175.558 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ
Novavax
NVAX
#5751
Rank
S$1.45 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
S$8.95
Share price
0.73%
Change (1 day)
-19.40%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Novavax (NVAX) - Cash on Hand

Cash on Hand as of September 2025 : S$0.98 Billion

According to Novavax's latest financial reports the company has S$0.98 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novavax - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$1.25 B67.12%
2023-12-31S$0.75 B-58.11%
2022-12-31S$1.79 B-12.5%
2021-12-31S$2.04 B117.75%
2020-12-31S$0.94 B785.19%
2019-12-31S$0.10 B-15.57%
2018-12-31S$0.12 B-40.17%
2017-12-31S$0.21 B-38.27%
2016-12-31S$0.34 B4.46%
2015-12-31S$0.32 B46.93%
2014-12-31S$0.22 B31.71%
2013-12-31S$0.16 B212.54%
2012-12-31S$53.94 M127.5%
2011-12-31S$23.71 M-41.89%
2010-12-31S$40.8 M-32.33%
2009-12-31S$60.29 M24.38%
2008-12-31S$48.48 M-27.53%
2007-12-31S$66.89 M-40.72%
2006-12-31S$0.11 B112.52%
2005-12-31S$53.1 M82.09%
2004-12-31S$29.16 M-37.88%
2003-12-31S$46.94 M800.41%
2002-12-31S$5.21 M-85.95%
2001-12-31S$37.1 M44.04%
2000-12-31S$25.76 M2110.34%
1999-12-31S$1.16 M-29.41%
1998-12-31S$1.65 M-74.23%
1997-12-31S$6.4 M83.12%
1996-12-31S$3.49 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Agenus
AGEN
S$4.48 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$1.10 B 11.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.31 B-67.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$0.27 B-72.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$10.60 B 972.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$19.41 B 1,864.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$12.63 B 1,178.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
S$2.01 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$5.75 B 482.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
S$0.75 B-23.55%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com